Euphoesulatin A

Euphoesulatin A has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Nov 23, 2021: “Euphoesulatin A prevents osteoclast differentiation and bone loss via inhibiting RANKL-induced ROS production and NF-κB and MAPK signal pathways”.

1 paper studies it1 findingUpdated Nov 23, 2021

See all 1 papers on euphoesulatin A

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

1 lab in 1 country

Funder: National Natural Science Foundation of China

Animals1

What did studies of euphoesulatin A find?

1

Studies of euphoesulatin A measured one outcome, bone loss.

Bone loss

downin mice1

1 study

Euphoesulatin A prevents bone loss in mice (ovariectomized mice).
“Eup A (10 mg/kg) significantly prevented bone loss in ovariectomized mice.”
Animalsovariectomized micebone10 mg/kg
Euphoesulatin A prevents osteoclast differentiation and bone loss via inhibiting RANKL-induced ROS production and NF-κB and MAPK signal pathways
Bioorganic chemistryNov 23, 2021

Latest

Bioorganic ChemistryDec 1

Euphoesulatin A prevents osteoclast differentiation and bone loss via inhibiting RANKL-induced ROS production and NF-κB and MAPK signal pathways

Experiments in miceBones and joints